
Peek Behind the Paper – Danilo Buonsenso on pediatric Long Covid
In this ‘Peek Behind the Paper’ feature, we take a look behind the scenes of…
In this ‘Peek Behind the Paper’ feature, we take a look behind the scenes of…
Differences in lung physiology and immune function in children may lie behind their decreased rates of symptomatic infections, hospitalization and death, according to a study from The University of Texas and Baylor College of Medicine (both TX, USA).
A novel study conducted by researchers at Harvard Medical School (MA, USA) has identified how the maternal gut microbiome could protect their newborn children from E. coli infection.
Researchers have developed an animal model mimicking HIV infection in infants, potentially allowing the development of therapeutics and interventions for the pediatric population.
Maternal infections, including influenza, can lead to higher rates of adverse fetal outcomes. New research suggests high levels of choline during gestation could mitigate this impact.
Concurrent major US and Canadian clinical trials prove probiotics to be ineffective in combatting gastroenteritis in children.
GARDP and Novartis have announced a partnership hoping to accelerate the development and availability of generic antibiotics for children in LMICs.
Trends in Acinetobacter baumannii infections, one of the most prevalent hospital-acquired infections in children, have been studied revealing that both cephalosporin and carbapenem resistance has increased.
Research presented at ECCMID suggests unvaccinated teenagers and adults were at highest risk of developing measles, whilst the biggest threat of mortality was to those under the age of two.